The comparison of these individuals with the patient group resulted again in the CYP4F2 433 VM/MM genotypes being associated with a lower risk of DKD (OR = 0.42 (0.22–0.80), p = 0.006; Table 4). This evidence concerns the gene CYP4F2 and diabetic kidney disease.